Posts Tagged 'drospirenone'

Women at particular risk from faulty hip implants

Although metal-on-metal hip implants have high failure rates for both sexes, women in particular have suffered from receiving the faulty devices, according to a report in the Guardian.

U.K. joint replacement experts called for the metal-on-metal implants – where both the ball and socket are coated in metal – to be banned following the medical journal Lancet’s release of a report earlier this week finding “unequivocal evidence” of high early failure rates.

The research, based on the National Joint Registry of England ...

continue reading...

FDA panel illustrates need for open records

From March 11 through 17, journalists, civic groups, nonprofits and other open government advocates are observing “Sunshine Week,” which is a national initiative to promote the importance of public access to government records and keeping government officials accountable.

The event’s name comes from the term “sunshine laws,” commonly used to describe the open records requirements that symbolically shine a light on government functions. Appropriately enough, Sunshine Week got its start in Florida in 2002. Editorial pages throughout the country have been ...

continue reading...

FDA OKs Bayer contraceptive for heavy bleeding

The U.S. Food and Drug Administration has approved the use of German corporation Bayer’s birth control pill Natazia for the treatment of heavy menstrual bleeding, according to RTTNews.

The report quotes Bayer’s Dr. Flemming Ornskov as saying: “As the first combined oral contraceptive treatment for heavy menstrual bleeding, Natazia represents a non-invasive treatment approach for this medical condition in addition to our intrauterine system Mirena. Both products underline Bayer’s ongoing commitment to advancing women’s health by providing them with multiple treatment ...

continue reading...

March 2012 Yaz/Beyaz Settlement Update

The Court of Common Pleas in Philadelphia has delayed trial deadlines in the cases over Yaz/Yasmin/Beyaz birth control for another 60 days. This puts the deadlines in Philadelphia on par with the U.S. District Court, which issued an order extending deadlines on Feb. 29.

Judge Sandra Moss announced the latest extension on March 9, 2012, referencing the District Court order, which will allow the parties in the case more time to negotiate.

Lopez McHugh is representing multiple plaintiffs against Bayer Healthcare, ...

continue reading...

Bayer expects new drugs to generate billions

German corporation Bayer has announced that its four most promising drugs, led by newly-launched anti-clotting pill Xarelto, may account for combined annual sales of as much as $6.5 billion, according to a Reuters report.

The report says Bayer’s healthcare division is aiming for sales of roughly $26.2 billion in 2014, up from $22.4 billion last year.

The company said prescription drug sales were set to rise to about $15 billion by 2014, up 16 percent from 2011, fueled largely by new product ...

continue reading...

Study: Temporary increased cancer risk from hormonal birth control

Medpage Today reports about a South African study that found a temporary increased risk of breast and cervical cancer associated with hormone contraceptives.

According to the study, women who recently used an injectable or oral hormone contraceptive were about 1.7 times more likely to develop breast cancer and 1.4 times more likely to develop cervical cancer than women who never used them, but the risk disappeared a few years after the women stopped taking the medication.

Numerous studies have also linked certain ...

continue reading...
Page 25 of 28 «...10202324252627...»